Pancreatic Safety of Sitagliptin in the TECOS Study.

JB, Buse; MA, Bethel; JB, Green; SR, Stevens; Y, Lokhnygina; P, Aschner; CR, Grado; T, Tankova; J, Wainstein; R, Josse; JM, Lachin; SS, Engel; K, Patel; ED, Peterson; RR, Holman

doi:10.2337/dc15-2780

Public

Pancreatic Safety of Sitagliptin in the TECOS Study.

Shared by NobleBlocks on Sep 14, 2016 • 12:00 AM UTC

Authors:

Buse JB

Bethel MA

Green JB

Abstract

Objective We evaluated the incidence of acute pancreatitis and pancreatic cancer in patients with type 2 diabetes and cardiovascular disease who were treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i).Research design and methods In the Trial Evaluating Cardiovascular Outcomes with...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!